Bill > S10466

This bill allows for prescription labels for certain medications, including gonadotropin-releasing hormone agonists (hormones that can suppress puberty), pubertal suppressants (medications that temporarily halt puberty), anabolic steroids, alpha reductase inhibitors (drugs that can affect hormone levels), progestins (a type of hormone), and hormone replacement therapy drugs used to treat gender dysphoria, to display the name of the dispensing healthcare practice instead of the individual prescriber, provided the prescriber requests this change and informs the patient.